(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride(CAS: 82586-52-5)

This compound is subject to the Globally Harmonized System (GHS) of Classification and Labelling of Chemicals, REACH regulations in the EU, and FDA/EPA requirements in the US. It is classified as a pharmaceutical intermediate and should comply with relevant toxicological and environmental regulations.

Synthetic alternatives include using similar isoquinoline derivatives or substituting the amino acid component with isomers or analogs. Common reagents include ethyl chloroformate or other amino acid precursors, but careful selection is necessary to ensure desired properties.

Research trends focus on its use as a pharmaceutical intermediate, particularly in antiviral and anti-inflammatory drug development. Market trends indicate increasing demand due to advancements in medicinal chemistry and biopharmaceutical research.

Waste should be collected in appropriate containers, labeled with the CAS number, and disposed of through professional waste management services. Incineration or chemical neutralization methods are suitable for safe disposal, ensuring compliance with environmental and safety regulations.